About: Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 January 1998

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в січні 1998 (uk) articolo scientifico (pubblicato il 1998) (it) im Januar 1998 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xineru de 1998 (ast) scientific article published on 01 January 1998 (en) artikull shkencor i botuar më 01 janar 1998 (sq)
publication date	wds:Q74105836-DB15ACBF-EAA2-489E-AC6E-0E8D4A60609C
publication date	1998-01-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q74105836-ADD33C64-EFA8-4591-8A4B-864B401A27AE
language of work or name	English
author name string	wds:Q74105836-008E9F1F-A9C5-451B-8ED5-A2DFD60322BA wds:Q74105836-04267574-49F1-48C8-88A1-F67E8E432C2F wds:Q74105836-227A96A4-6BB3-4899-905B-7E619B4B669A wds:Q74105836-2A057013-2552-4988-9FB1-434F63C72C0C wds:Q74105836-752490E9-E0B7-4B27-B058-EB8C0AD15A8C wds:Q74105836-B4EFFDD8-276F-4CF6-ACBE-8A5AE088E79C wds:Q74105836-DD197602-9153-4FD1-A149-37EB2306B61A wds:Q74105836-E1D02DBF-EF40-4B20-96D1-786C38A2CB88
author name string	I Tabas X Jiang J H Rapp J Najib S L Schissel T Jeong E H Camejo J Tweedie-Hardman
rdfs:label	Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development (en) Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development (nl) Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development (sq)
skos:prefLabel	Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development (en) Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development (nl) Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development (sq)
name	Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development (en) Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development (nl) Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development (sq)
author	wds:Q74105836-4FF7F256-42B3-4747-8001-44AD5A644679
author	Kevin Jon Williams
title	wds:Q74105836-65D0863C-EC48-4F7A-A562-DDEA1726FBBF
title	Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development (en)
page(s)	wds:Q74105836-4F7341BB-5DF0-4A90-88E7-E021BC5B1FE2
page(s)	2738-2746
instance of	wds:Q74105836-99CE3C08-C659-4B86-849E-C47A7266C0C3
instance of	scholarly article
PubMed ID	wds:Q74105836-E1DC6F15-21A8-48CD-8D58-DEB356079638
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9446580
PubMed ID	9446580
published in	wds:Q74105836-2B0F9C2C-EDC7-465E-8F26-5314B4D3D101
published in	Journal of Biological Chemistry
issue	wds:Q74105836-5928544C-2AB4-4746-A966-CA66EE8BF180
volume	wds:Q74105836-8C6AC79F-9A16-4CEF-8B47-84AE051C7D7E
issue	5
volume	273
number of pages	wds:Q74105836-E928BADF-7A22-4FE0-942A-AF764028A9B2
number of pages	9 (xsd:decimal)
DOI	wds:Q74105836-C75A253D-7D86-49A3-8E10-5BF7AF27737F
DOI	http://dx.doi.org/10.1074/JBC.273.5.2738
DOI	10.1074/JBC.273.5.2738
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q74105836
is cites work of	Brain pathology in Niemann Pick disease type A: insights from the acid sphingomyelinase knockout mice Ceramide-rich platforms in transmembrane signaling Caveolae internalization repairs wounded cells and muscle fibers. Studies on the role of acid sphingomyelinase and ceramide in the regulation of tumor necrosis factor alpha (TNFalpha)-converting enzyme activity and TNFalpha secretion in macrophages Regulated secretion of acid sphingomyelinase: implications for selectivity of ceramide formation. Association of apo B lipoproteins with arterial proteoglycans: pathological significance and molecular basis Sphingomyelin phosphodiesterase acid-like 3A (SMPDL3A) is a novel nucleotide phosphodiesterase regulated by cholesterol in human macrophages Radiation and ceramide-induced apoptosis Genetic determinants of circulating sphingolipid concentrations in European populations Deregulation of sphingolipid metabolism in Alzheimer's disease The therapeutic potential of modulating the ceramide/sphingomyelin pathway Recent advances in the immunobiology of ceramide The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases Roles and regulation of secretory and lysosomal acid sphingomyelinase Sphingolipid signalling domains floating on rafts or buried in caves? Physiology and pathophysiology of sphingolipid metabolism and signaling Characterization of human acid sphingomyelinase purified from the media of overexpressing Chinese hamster ovary cells Ceramide and apoptosis Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance Phospholipids and oxophospholipids in atherosclerotic plaques at different stages of plaque development. Why Is Apolipoprotein CIII Emerging as a Novel Therapeutic Target to Reduce the Burden of Cardiovascular Disease? ApoCIII-enriched LDL in type 2 diabetes displays altered lipid composition, increased susceptibility for sphingomyelinase, and increased binding to biglycan Ceramide and mitochondria in ischemia/reperfusion Ceramide and cell death receptor clustering Exocytosis of acid sphingomyelinase by wounded cells promotes endocytosis and plasma membrane repair Trypanosoma cruzi subverts the sphingomyelinase-mediated plasma membrane repair pathway for cell invasion Sphingomyelinase treatment induces ATP-independent endocytosis Interactions between metabolism and intracellular distribution of cholesterol and sphingomyelin Sphingomyelinases: enzymology and membrane activity Magnesium deficiency upregulates sphingomyelinases in cardiovascular tissues and cells: cross-talk among proto-oncogenes, Mg(2+), NF-κB and ceramide and their potential relationships to resistant hypertension, atherogenesis and cardiac failure Acid sphingomyelinase promotes lipoprotein retention within early atheromata and accelerates lesion progression Unique cellular events occurring during the initial interaction of macrophages with matrix-retained or methylated aggregated low density lipoprotein (LDL). Prolonged cell-surface contact during which ldl-cholesteryl ester hydrolysis exceeds ldl prot Inhibition of cytokine signaling in human retinal endothelial cells through downregulation of sphingomyelinases by docosahexaenoic acid Ceramide function in the brain: when a slight tilt is enough. Host cell invasion by Trypanosoma cruzi: a unique strategy that promotes persistence Neutral sphingomyelinase: past, present and future Sphingomyelinase Induces Aggregation and Fusion, but Phospholipase A2Only Aggregation, of Low Density Lipoprotein (LDL) Particles Pharmacological reversion of sphingomyelin-induced dendritic spine anomalies in a Niemann Pick disease type A mouse model You are right too! Sphingolipid metabolism and obesity-induced inflammation

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software